Overview

A Study to Evaluate the Effects of ACT-541468 on Respiration in Patients With Moderate Chronic Obstructive Pulmonary Disease

Status:
Completed

Trial end date:
2019-09-19

Target enrollment:

Participant gender:

Summary

A study to evaluate the effects of ACT-541468 on respiration in patients with moderate chronic obstructive pulmonary disease

Phase:

Phase 1

Details

Lead Sponsor:

Idorsia Pharmaceuticals Ltd.